The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 05, 2019
Filed:
Jun. 02, 2017
Applicant:
Novira Therapeutics, Inc., Doylestown, PA (US);
Inventors:
George D. Hartman, Lansdale, PA (US);
Osvaldo A. Flores, North Wales, PA (US);
Assignee:
NOVIRA THERAPEUTICS, INC., Doylestown, PA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 311/37 (2006.01); C07D 401/06 (2006.01); C07D 213/74 (2006.01); C07D 213/82 (2006.01); C07D 401/12 (2006.01); C07D 205/04 (2006.01); C07D 265/30 (2006.01); C07D 207/08 (2006.01); C07D 265/32 (2006.01); C07D 207/09 (2006.01); C07D 207/12 (2006.01); C07D 207/14 (2006.01); C07D 207/16 (2006.01); C07D 211/22 (2006.01); C07D 211/32 (2006.01); C07D 211/42 (2006.01); C07C 211/46 (2006.01); C07C 211/48 (2006.01); C07C 211/50 (2006.01); C07D 211/52 (2006.01); C07D 211/58 (2006.01); C07D 211/62 (2006.01); C07D 295/26 (2006.01); A61K 31/397 (2006.01); A61K 31/40 (2006.01); A61K 31/445 (2006.01); A61K 45/06 (2006.01); C07C 311/46 (2006.01); C07D 207/48 (2006.01); C07D 211/96 (2006.01); A61K 38/21 (2006.01); A61K 31/407 (2006.01); A61K 31/496 (2006.01); A61K 31/513 (2006.01); A61K 31/52 (2006.01); A61K 31/536 (2006.01); A61K 31/551 (2006.01); A61K 31/675 (2006.01); A61K 31/7072 (2006.01); A61K 31/4015 (2006.01); A61K 31/4453 (2006.01); A61K 31/451 (2006.01); A61K 31/522 (2006.01); A61K 31/18 (2006.01); A61K 31/4545 (2006.01); A61K 31/495 (2006.01); A61K 31/5375 (2006.01); C07D 295/195 (2006.01); A61K 31/167 (2006.01); A61K 31/454 (2006.01);
U.S. Cl.
CPC ...
C07D 401/06 (2013.01); A61K 31/167 (2013.01); A61K 31/18 (2013.01); A61K 31/397 (2013.01); A61K 31/40 (2013.01); A61K 31/407 (2013.01); A61K 31/4015 (2013.01); A61K 31/445 (2013.01); A61K 31/4453 (2013.01); A61K 31/451 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01); A61K 31/513 (2013.01); A61K 31/52 (2013.01); A61K 31/522 (2013.01); A61K 31/536 (2013.01); A61K 31/5375 (2013.01); A61K 31/551 (2013.01); A61K 31/675 (2013.01); A61K 31/7072 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); C07C 211/46 (2013.01); C07C 211/48 (2013.01); C07C 211/50 (2013.01); C07C 311/46 (2013.01); C07D 205/04 (2013.01); C07D 207/08 (2013.01); C07D 207/09 (2013.01); C07D 207/12 (2013.01); C07D 207/14 (2013.01); C07D 207/16 (2013.01); C07D 207/48 (2013.01); C07D 211/22 (2013.01); C07D 211/32 (2013.01); C07D 211/42 (2013.01); C07D 211/52 (2013.01); C07D 211/58 (2013.01); C07D 211/62 (2013.01); C07D 211/96 (2013.01); C07D 213/74 (2013.01); C07D 213/82 (2013.01); C07D 265/30 (2013.01); C07D 265/32 (2013.01); C07D 295/195 (2013.01); C07D 295/26 (2013.01); C07D 401/12 (2013.01);
Abstract
The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.